Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

Stopped For administrative reasons. Enrollment was sufficient to have statistical power without compromising the integrity of the study data

Conditions

• Renal Impairment

Interventions

• DRUG: Elinogrel

Sponsor

Portola Pharmaceuticals

Collaborators

• [object Object]